Results 311 to 320 of about 104,507 (343)
Some of the next articles are maybe not open access.

Quinolones: pharmacology

Pharmaceutisch Weekblad Scientific Edition, 1986
The quinolones are synthetic antibiotics chemically related to nalidixic acid. Since its introduction, several structural analogues have been synthesized. A fundamental breakthrough was the addition of a fluorine atom. The quinolones interfere with bacterial DNA transcription by inhibiting the enzyme DNA gyrase, that so far has only been found in ...
openaire   +2 more sources

Quinolones in the Aged

Drugs, 1999
Pharmacokinetic studies of fluoroquinolone antibacterials generally demonstrate some quantitative alterations in elderly compared with younger populations. The most common observations are an increased maximal plasma drug concentration and area under the concentration-time curve, which are primarily attributable to the 10 to 15% decrease in lean body ...
openaire   +2 more sources

Occurrence and transport of tetracycline, sulfonamide, quinolone, and macrolide antibiotics in the Haihe River Basin, China.

Environmental Science and Technology, 2011
The occurrence and transport of 12 antibiotics (from the tetracycline, sulfonamide, quinolone, and macrolide families) was studied in a 72-km stretch of the Haihe River, China, and in six of its tributaries.
Yi Luo   +5 more
semanticscholar   +1 more source

Quinolone Resistance

2003
Quinolone antibacterial agents were first introduced into the clinical environment in the early 1960s. The first qumolone to be clinically used was nalidixic acid, which was used for the treatment of enteric and urinary tract infections. As a result of increased clinical resistance to this drug, its use has declined.
J C, Brown, S G, Amyes
openaire   +2 more sources

The Quinolones

Mayo Clinic Proceedings, 1987
The fluoroquinolones are a new class of antimicrobial agents structurally related to nalidixic acid. They have a broad spectrum of activity against pathogens, including Pseudomonas aeruginosa, other multiresistant gram-negative bacteria, and methicillin-resistant Staphylococcus aureus but not anaerobes. They are well absorbed after oral administration,
Walker Rc, Wright Aj
openaire   +3 more sources

Quinolone pharmacokinetics in the elderly

The American Journal of Medicine, 1992
As a class, quinolones undergo both renal excretion and hepatic metabolism. The dominant elimination pathway is usually renal, where secretion by the proximal tubule results in renal clearances 1.5-4 times greater than creatinine clearance. The benefit of this two-pathway elimination is protection from excessive accumulation in patients with single ...
Jerome J. Schentag, Thomas F. Goss
openaire   +3 more sources

Quinolones in Gastrointestinal Infections

Chemotherapy, 1996
Fluoroquinolones are efficient antimicrobial drugs for the treatment of enteric fever, shigellosis, Escherichia coli diarrhea, cholera, and traveler's diarrhea. They also play a role in the therapy of yersiniosis, campylobacteriosis, and intestinal salmonellosis. A single dose of quinolones has been effective in the treatment of traveler's diarrhea and
H. Laferl   +3 more
openaire   +3 more sources

Quinolone pharmacokinetics

International Journal of Antimicrobial Agents, 1992
Fluoroquinolones have broad antibacterial spectra and are active against most Gram-negative and many Gram-positive species. They exhibit excellent oral bioavailability, extensive tissue penetration, low protein binding, and a long elimination half-life.
openaire   +2 more sources

Fluorinated quinolones — new quinolone antimicrobials

1992
Paul Ehrlich started his research, called experimental chemotherapy, in 1902, and discovered Trypanrot in 1904 and Salvarsan in 1909. This was the first success of chemotherapy using man-made chemotherapeutic agents against microorganisms. Since the original observation by Fleming in 1929 of the effect of Penicillium notatum on a culture plate in his ...
K. Hirai   +16 more
openaire   +2 more sources

The Quinolones

Clinical Pharmacokinetics, 1992
The fluoroquinolones represent a relatively new class of antibiotics with outstanding therapeutic potential, attributable to their broad spectrum of antimicrobial activity and favourable tissue distribution. They are highly active against most Gram-negative pathogens, as well as Staphylococcus aureus and coagulase-negative staphylococci.
openaire   +3 more sources

Home - About - Disclaimer - Privacy